Robert Redd
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 34
- Hematology top 1%
- Multiple Myeloma Research and Treatments 16
- Acute Myeloid Leukemia Research 11
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 23
- Oncology top 2%
- CAR-T cell therapy research 23
- Cancer Treatment and Pharmacology 9
- Immunology top 5%
-
- Cancer Genomics and Diagnostics 9
-
- Protein Degradation and Inhibitors 9
- Co-authors
- Donna NeubergScott J. RodigMargaret A. ShippPhilippe ArmandBjoern ChapuyAzra H. LigonGordon J. FreemanRichard T. Hoppe
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Robert Redd
96 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Pathology and Forensic Medicine 1.3k
- Hematology 678
- Genetics 636
- Oncology 1.5k
- Immunology 888
Countries citing papers authored by Robert Redd
This map shows the geographic impact of Robert Redd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Redd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Redd more than expected).
Fields of papers citing papers by Robert Redd
This network shows the impact of papers produced by Robert Redd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Redd. The network helps show where Robert Redd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Redd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 18 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 88 | |
| 16 | 2020 | 32 | |
| 17 | 2020 | 23 | |
| 18 | 2019 | 79 | |
| 19 | 2018 | 111 | |
| 20 | 2016 | 139 |
About Robert Redd
Robert Redd is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 102 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (23 papers), CAR-T cell therapy research (23 papers), Multiple Myeloma Research and Treatments (16 papers), Acute Myeloid Leukemia Research (11 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Treatment and Pharmacology (9 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.3k citations), Hematology (678 citations) and Genetics (636 citations). Robert Redd has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Donna Neuberg, Scott J. Rodig, Margaret A. Shipp, Philippe Armand, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Richard T. Hoppe, Courtney Connelly and Sarah E. Daadi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Clinical Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.